A4R | Accountability for reasonableness |
AWP | Average wholesale price |
BIA | Budget impact analysis |
BTD | Better than dead |
BWS | Best-worst scaling |
CCA | Cost-consequence analysis |
CEA | Cost-effectiveness analysis |
CEAC | Cost-effectiveness acceptability curve |
CER | Comparative effectiveness research |
CMA | Cost-minimization analysis |
COI | Conflict of interest |
CQ | Clinical question |
CSIMC | Central Social Insurance Medical Council (Chuikyo) [Japan] |
CUA | Cost-utility analysis |
CVM | Contingent caluation method |
DALY | Disability-adjusted life year |
DCE | Discrete choice experiment |
DPC | Diagnosis Procedure Combination [Japan] |
DRG | Diagnosis Related Groups |
EOL | End-of-life |
EVPI | Expected value of perfect information |
EVPPI | Expected value of partially perfect information |
EVSI | Expected value of sample information |
HRQOL | Health-related quality of life |
HTA | Health technology assessment |
ICER | Incremental cost-effectiveness ratio |
INB | Incremental net benefit |
IPD | Individual participant data |
LY | Life year |
MCDA | Multi criteria decision analysis |
MTC | Multiple treatment comparison |
NHS | National Health Service |
NMB | Net monetary benefit |
NICE | The National Institute for Health and Care Excellence |
PBM | Preference-based measure |
PDPS | Per-Diem Payment System [Japan] |
PE | Pharmacoeconomics |
PPS | Prospective Payment System |
PRO | Patient-reported outcome |
PSA | Probabilistic sensitivity analysis |
QALY | Quality-adjusted life year |
QOL | Quality of life |
RCT | Randomized controlled trial |
SG | Standard gamble |
SR | Systematic review |
TA | Technology appraisal |
TTO | Time trade-off |
VAS | Visual analogue scale |
VBP | Value-based pricing |
VOI | Value of information |
WTA | Willingness to accept |
WTD | Worse than dead |
WTP | Wilingness to pay |
Abbreviations
List of abbreviations in health technology assessment (alphabetic order)